<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Fri, 11 Jul 2025 17:01:49 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis</title><link>https://www.2minutemedicine.com/nerandomilast-slows-decline-in-fvc-in-idiopathic-pulmonary-fibrosis/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/06/PD_lungs_edited-300x150.png</image_url><description>1. In this randomized trial, among patients with idiopathic pulmonary fibrosis (IPF), nerandomilast slowed the decline in the forced vital capacity (F...</description><pubDate>Fri, 11 Jul 2025 18:00:21 GMT</pubDate></item><item><title>Mazdutide significantly reduces weight in adults with overweight or obesity</title><link>https://www.2minutemedicine.com/mazdutide-significantly-reduces-weight-in-adults-with-overweight-or-obesity/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2016/09/scale2_PD_edited-300x150.jpg</image_url><description>1. In this randomized controlled trial, weekly administration of Mazdutide resulted in significant weight reduction in adults classified as overweight...</description><pubDate>Fri, 11 Jul 2025 15:00:26 GMT</pubDate></item><item><title>Oral vancomycin may be effective for pouchitis in inflammatory bowel disease</title><link>https://www.2minutemedicine.com/oral-vancomycin-may-be-effective-for-pouchitis-in-inflammatory-bowel-disease/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2018/12/Crohn_Colitis_6264520294-300x150.jpg</image_url><description>1. In patients with pouchitis associated with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC), the use of oral vancomycin wa...</description><pubDate>Fri, 11 Jul 2025 00:00:20 GMT</pubDate></item><item><title>Inebilizumab improves outcome in patients generalized myasthenia gravis</title><link>https://www.2minutemedicine.com/inebilizumab-improves-outcome-in-patients-generalized-myasthenia-gravis/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2013/06/Antibody_IgG2_edited-300x150.png</image_url><description>1. In patients with myasthenia gravis (MG) who had anti-acetylcholine receptor antibodies or anti-muscle-specific kinase antibodies, intravenous inebi...</description><pubDate>Thu, 10 Jul 2025 18:00:51 GMT</pubDate></item><item><title>Medbridge turns any phone into a motion-capture coach for at-home rehab</title><link>https://www.2minutemedicine.com/medbridge-turns-any-phone-into-a-motion-capture-coach-for-at-home-rehab/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2014/10/Young_people_texting_on_smartphones_using_thumbs-300x225.jpg</image_url><description>Key points: 1. Medbridgeâ€™s new smartphone-based motion-capture tool tracks rehab exercises in real time, improving adherence and reducing hardware cos...</description><pubDate>Thu, 10 Jul 2025 15:00:15 GMT</pubDate></item></channel></rss>